Cover Image

Commentary for "antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy"

Saved in:

Bibliographic Details
Main Authors:	Ashok D. Prabakaran (Author), Manoj Panta (Author), Mattia Quattrocelli (Author)
Format:	Book
Published:	Wiley, 2022-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of circadian time of dosing on cardiomyocyte-autonomous effects of glucocorticoids
by: Michelle Wintzinger, et al.
Published: (2022)

Potential Therapeutic Strategies for Skeletal Muscle Atrophy
by: Li Huang, et al.
Published: (2022)

Urotensin II Induces Mice Skeletal Muscle Atrophy Associated with Enhanced Autophagy and Inhibited Irisin Precursor (Fibronectin Type III Domain Containing 5) Expression in Chronic Renal Failure
by: Ya-Jing Pan, et al.
Published: (2019)

Potential Clinical Implications of the Urotensin II Receptor Antagonists
by: Emilie Kane, et al.
Published: (2011)

Obestatin signalling counteracts glucocorticoid‐induced skeletal muscle atrophy via NEDD4/KLF15 axis
by: Tania Cid‐Díaz, et al.
Published: (2021)

Regulation of skeletal muscle atrophy
by: Shigetada Teshima-Kondo, et al.
Published: (2013)

Effects of urotensin II receptor antagonist, GSK1440115, in asthma
by: Alison D Portnoy, et al.
Published: (2013)

Inflammation: Roles in Skeletal Muscle Atrophy
by: Yanan Ji, et al.
Published: (2022)

Increased Serpina3n release into circulation during glucocorticoid‐mediated muscle atrophy
by: Marine Gueugneau, et al.
Published: (2018)

Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas
by: María Gabriela Morales, et al.
Published: (2016)

Glucocorticoid-Induced Skin Atrophy: The Old and the New
by: Niculet E, et al.
Published: (2020)

Gromwell ameliorates glucocorticoid-induced muscle atrophy through the regulation of Akt/mTOR pathway
by: Ahyoung Yoo, et al.
Published: (2024)

Role of Ca2+ signaling in skeletal muscle hypertrophy and atrophy
by: Naoki Ito, et al.
Published: (2015)

Involvement of phosphatidylserine receptors in the skeletal muscle regeneration: therapeutic implications
by: Zsuzsa Szondy, et al.
Published: (2022)

Potential of Lycii Radicis Cortex as an Ameliorative Agent for Skeletal Muscle Atrophy
by: Rak Ho Son, et al.
Published: (2024)

Aspiration pneumonia induces muscle atrophy in the respiratory, skeletal, and swallowing systems
by: Riyo Komatsu, et al.
Published: (2018)

Quercetin Protects against Obesity-Induced Skeletal Muscle Inflammation and Atrophy
by: Ngoc Hoan Le, et al.
Published: (2014)

The G protein‐coupled receptor ligand apelin‐13 ameliorates skeletal muscle atrophy induced by chronic kidney disease
by: Yuki Enoki, et al.
Published: (2023)

Mechanism of Human Urotensin II-Induced Contraction in Rat Aorta
by: Katsunari Tasaki, et al.
Published: (2004)

The Role of Urotensin-II in Obesity and Metabolic Syndrome in Pediatric Population
by: Marko Simunovic, et al.
Published: (2022)

An investigation of postmortem urotensin II receptor levels in brain and kidney tissues in a rat model of cardiac ischemia
by: Mustafa Talip Sener, et al.
Published: (2018)

Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1
by: Zuhan He, et al.
Published: (2023)

Dynamic changes in the mouse skeletal muscle proteome during denervation-induced atrophy
by: Franziska Lang, et al.
Published: (2017)

Skeletal muscle atrophy, regeneration, and dysfunction in heart failure: Impact of exercise training
by: Harrison Gallagher, et al.
Published: (2023)

Effects of aging on unloading-induced skeletal muscle atrophy and subsequent recovery in rats
by: Hideki Yamauchi, et al.
Published: (2013)

Irisin is Associated with Urotensin II and Protein Energy Wasting in Hemodialysis Patients
by: Wan-Yu He, et al.
Published: (2016)

The Urotensin II System And Carotid Atherosclerosis: A Role In Vascular Calcification
by: Isabella eAlbanese, et al.
Published: (2016)

Skeletal muscle atrophy‐induced hemopexin accelerates onset of cognitive impairment in Alzheimer's disease
by: Tsukasa Nagase, et al.
Published: (2021)

Antagonism of CGRP Signaling by Rimegepant at Two Receptors
by: Kylie S. Pan, et al.
Published: (2020)

The glucocorticoid receptor acts locally to protect dystrophic muscle and heart during disease
by: Trinitee Oliver, et al.
Published: (2024)

Amelioration of muscle wasting by glucagon‐like peptide‐1 receptor agonist in muscle atrophy
by: Yeonhee Hong, et al.
Published: (2019)

Filamin C regulates skeletal muscle atrophy by stabilizing dishevelled-2 to inhibit autophagy and mitophagy
by: Shunshun Han, et al.
Published: (2022)

Stimulation of soluble guanylate cyclase by vericiguat reduces skeletal muscle atrophy of mice following chemotherapy
by: Bo-ang Hu, et al.
Published: (2023)

Skeletal Muscle Atrophy Was Alleviated by Salidroside Through Suppressing Oxidative Stress and Inflammation During Denervation
by: Ziwei Huang, et al.
Published: (2019)

Pharmacokinetics/pharmacodynamics of glucocorticoids: modeling the glucocorticoid receptor dynamics and dose/response of commonly prescribed glucocorticoids
by: David Levitt
Published: (2024)

Hypothalamic-pituitary-adrenal axis activation and glucocorticoid‐responsive gene expression in skeletal muscle and liver of Apc mice
by: Agnès Martin, et al.
Published: (2022)

Nuclear receptors and skeletal muscle fiber type
by: Wataru Mizunoya
Published: (2015)

The Relationship Between Urotensin-II Level and Carotid Intima Media Thickness in Dialysis Patients
by: Refika Büberci, et al.
Published: (2022)

Kinin B1 receptor antagonism is equally efficient as angiotensin receptor 1 antagonism in reducing renal fibrosis in experimental obstructive nephropathy, but is not additive.
by: Antoine eHuart, et al.
Published: (2015)

A novel alternatively spliced isoform of the mu-opioid receptor: functional antagonism
by: Wentworth Sean, et al.
Published: (2010)